GCL
DALS

Glazer Capital LLC’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Glazer Capital LLC’s Portfolio DALS Stock Details DALS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-21,990
Closed -$216K – 947
2021
Q3 		$216K Buy
+21,990
New +$217K ﹤0.01% 667

Other funds holding DALS

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Glazer Capital LLC's DALS Position: Q4 2021 in Review

Glazer Capital LLC sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q4 2021, closing a stake of 21,990 shares — an estimated $216K sold.

Glazer Capital LLC first reported a position in DALS in Q3 2021 and held it in 1 quarter. The position peaked at $216K in Q3 2021. 36 funds tracked by Wall St. Rank hold DALS as of Q4 2021.

  • Glazer Capital LLC reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q4 2021 after selling out during the quarter.
  • Glazer Capital LLC sold 21,990 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q4 2021, an estimated $216K.
  • Glazer Capital LLC first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q3 2021 and held it in 1 quarter.
  • Glazer Capital LLC's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $216K in Q3 2021.
  • 36 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q4 2021.

Based on Glazer Capital LLC's 13F filing for Q4 2021, filed 14 Feb 2022.